The closing price of Cerevel Therapeutics Holdings Inc. (NASDAQ: CERE) was $24.32 for the day, down -0.53% from the previous closing price of $24.45. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 666379 shares were traded. CERE stock price reached its highest trading level at $24.46 during the session, while it also had its lowest trading level at $23.42.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Our analysis of CERE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.50. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
On February 23, 2023, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $38 to $30.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $40.Loop Capital initiated its Buy rating on November 01, 2022, with a $40 target price.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 when COLES N ANTHONY sold 3,000 shares for $27.19 per share. The transaction valued at 81,570 led to the insider holds 2,704 shares of the business.
COLES N ANTHONY sold 47,000 shares of CERE for $1,274,377 on Mar 02. The CEO and Chairperson now owns 2,704 shares after completing the transaction at $27.11 per share. On Feb 07, another insider, COLES N ANTHONY, who serves as the CEO and Chairperson of the company, sold 50,000 shares for $33.13 each. As a result, the insider received 1,656,401 and left with 2,704 shares of the company.
Stock Price History:
Over the past 52 weeks, CERE has reached a high of $41.46, while it has fallen to a 52-week low of $19.86. The 50-Day Moving Average of the stock is 30.67, while the 200-Day Moving Average is calculated to be 29.13.
CERE traded an average of 640.56K shares per day over the past three months and 672.31k shares per day over the past ten days. A total of 156.43M shares are outstanding, with a floating share count of 128.77M. Insiders hold about 17.56% of the company’s shares, while institutions hold 86.00% stake in the company. Shares short for CERE as of Jan 30, 2023 were 5.7M with a Short Ratio of 4.82M, compared to 4.94M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.65% and a Short% of Float of 12.30%.
The firm’s stock currently is rated by 10 analysts. On average, analysts expect EPS of -$0.64 for the current quarter, with a high estimate of -$0.61 and a low estimate of -$0.68, while EPS last year was -$0.4. The consensus estimate for the next quarter is -$0.66, with high estimates of -$0.63 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$2.19 and -$2.41 for the fiscal current year, implying an average EPS of -$2.35. EPS for the following year is -$2.64, with 10 analysts recommending between -$2.19 and -$2.94.